This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1997 Jan;276(1):52-9.

doi: 10.1038/scientificamerican0197-52.

Understanding Parkinson's disease

M B Youdim¹, P Riederer

Affiliations

PMID: 8972618
DOI: 10.1038/scientificamerican0197-52

Understanding Parkinson's disease

M B Youdim et al. Sci Am. 1997 Jan.

. 1997 Jan;276(1):52-9.

doi: 10.1038/scientificamerican0197-52.

Authors

M B Youdim¹, P Riederer

Affiliation

¹ Technion-Israel Institute of Technology, Haifa, Israel.

PMID: 8972618
DOI: 10.1038/scientificamerican0197-52

No abstract available

PubMed Disclaimer

Similar articles

Aetiology and natural history of Parkinson's disease.
Pearce JM. Pearce JM. Br Med J. 1978 Dec 16;2(6153):1664-6. doi: 10.1136/bmj.2.6153.1664-a. Br Med J. 1978. PMID: 32952 Free PMC article. Review. No abstract available.
[Search for the cause of Parkinson's disease].
Langston JW. Langston JW. Arch Neurobiol (Madr). 1991 Nov-Dec;54(6):264-71. Arch Neurobiol (Madr). 1991. PMID: 1811457 Review. Spanish. No abstract available.
Free radicals and their scavengers in Parkinson's disease.
Yoshikawa T. Yoshikawa T. Eur Neurol. 1993;33 Suppl 1:60-8. doi: 10.1159/000118539. Eur Neurol. 1993. PMID: 8375435 Review.
Role of the nigrostriatal dopaminergic neurons in mediating the effect of exogenous L-dopa in Parkinson's disease.
Melamed E. Melamed E. Mt Sinai J Med. 1988 Jan;55(1):35-42. Mt Sinai J Med. 1988. PMID: 3279303 Review. No abstract available.
Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients.
Prescott IA, Dostrovsky JO, Moro E, Hodaie M, Lozano AM, Hutchison WD. Prescott IA, et al. Brain. 2009 Feb;132(Pt 2):309-18. doi: 10.1093/brain/awn322. Epub 2008 Dec 2. Brain. 2009. PMID: 19050033

See all similar articles

Cited by

Neuroprotection or Neurotoxicity of Illicit Drugs on Parkinson's Disease.
Ferreira C, Almeida C, Tenreiro S, Quintas A. Ferreira C, et al. Life (Basel). 2020 Jun 11;10(6):86. doi: 10.3390/life10060086. Life (Basel). 2020. PMID: 32545328 Free PMC article. Review.
Tempol protects blood proteins and lipids against peroxynitrite-mediated oxidative damage.
Mustafa AG, Bani-Ahmad MA, Jaradat AQ, Allouh MZ. Mustafa AG, et al. Exp Biol Med (Maywood). 2015 Jan;240(1):109-12. doi: 10.1177/1535370214546291. Epub 2014 Aug 8. Exp Biol Med (Maywood). 2015. PMID: 25107897 Free PMC article.
Neuroinflammation-Induced Upregulation of Glial Cathepsin X Expression and Activity in vivo.
Pišlar A, Tratnjek L, Glavan G, Zidar N, Živin M, Kos J. Pišlar A, et al. Front Mol Neurosci. 2020 Nov 20;13:575453. doi: 10.3389/fnmol.2020.575453. eCollection 2020. Front Mol Neurosci. 2020. PMID: 33328882 Free PMC article.
Neuroprotective strategies in Parkinson's disease : an update on progress.
Mandel S, Grünblatt E, Riederer P, Gerlach M, Levites Y, Youdim MB. Mandel S, et al. CNS Drugs. 2003;17(10):729-62. doi: 10.2165/00023210-200317100-00004. CNS Drugs. 2003. PMID: 12873156 Review.
Altered expression of hypothetical proteins in hippocampus of transgenic mice overexpressing human Cu/Zn-superoxide dismutase 1.
Shin JH, Yang JW, Le Pecheur M, London J, Hoeger H, Lubec G. Shin JH, et al. Proteome Sci. 2004 Jun 11;2(1):2. doi: 10.1186/1477-5956-2-2. Proteome Sci. 2004. PMID: 15193154 Free PMC article.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Scientific American
Medical
- MedlinePlus Health Information